Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Protara Therapeutics, Inc. from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Protara Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q1 2020 to Q3 2025.
  • Protara Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 30 Sep 2025 was $364K, a 44.3% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

Protara Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $364K -$290K -44.3% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $430K -$307K -41.7% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $500K -$326K -39.5% 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $575K -$343K -37.4% 31 Dec 2024 10-K 05 Mar 2025
Q3 2024 $654K 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $737K 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $826K -$394K -32.3% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $918K -$410K -30.9% 31 Dec 2023 10-K 13 Mar 2024
Q1 2023 $1.22M 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $1.33M -$349K -20.8% 31 Dec 2022 10-K 08 Mar 2023
Q3 2022 $1.44M 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $1.56M 30 Jun 2022 10-Q 09 Aug 2022
Q4 2021 $1.68M -$7M -80.7% 31 Dec 2021 10-Q 05 May 2022
Q4 2020 $8.68M 31 Dec 2020 10-K 11 Mar 2021
Q3 2020 $230K 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 $228K 30 Jun 2020 10-Q 31 Jul 2020
Q1 2020 $240K 31 Mar 2020 10-Q 13 May 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.